STOCK TITAN

XOMA (XOMA) CIO receives stock, PSU grants and updates holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Sitko Bradley reported acquisition or exercise transactions in this Form 4 filing.

XOMA Royalty Corp’s Chief Investment Officer Bradley Sitko reported equity awards rather than market trades. He received 44,849 Performance Stock Units, each representing the right to one share of common stock if specified share-price goals are met and he remains with the company through the vesting dates.

He was also granted two blocks of common-stock RSUs at no cash cost: 30,000 shares and 29,402 shares. One RSU grant vests fully on March 11, 2031, and the other vests 25% on each of the first four anniversaries of March 11, 2026, all conditioned on continued service.

Following these grants, Sitko holds 79,224 shares of common stock directly, plus the 44,849 PSUs. He also reports direct holdings of preferred and depositary shares and additional indirect common and preferred holdings through a 401(k) plan, his spouse, and children.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sitko Bradley

(Last) (First) (Middle)
C/O XOMA ROYALTY CORPORATION
2200 POWELL STREET, SUITE 310

(Street)
EMERYVILLE CA 94608

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
XOMA Royalty Corp [ XOMA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Investment Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/11/2026 A 30,000(1) A $0 49,822 D
Common Stock 03/11/2026 A 29,402(2) A $0 79,224 D
8.625% Series A Cumulative Perpetual Preferred Stock 313 D
Depositary Shares - 8.375% Series B Cumulative Stock 7,045 D
Common Stock 829 I By 401(k) Plan
Common Stock 1,500 I By spouse
Common Stock 75 I By child
Common Stock 75 I By child
8.625% Series A Cumulative Perpetual Preferred Stock 82 I By spouse
Depositary Shares - 8.375% B Cumulative Stock 2,000 I By spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Stock Units (3) 03/11/2026 A 44,849 (3) (3) Common Stock 44,849 $0 44,849 D
Explanation of Responses:
1. Represents a grant of restricted stock units ("RSUs") payable solely in common stock that will vest in full on March 11, 2031, subject to the Reporting Person's continued service to the Issuer through the vesting date.
2. Represents a grant of RSUs payable solely in common stock that will vest as to 25% on each of the first four anniversaries of March 11, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.
3. Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock. The PSUs vest upon the common stock achieving a specified price per share, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Remarks:
/s/ Maricel Montano, Attorney-in-Fact for Bradley Sitko 03/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did XOMA (XOMA) CIO Bradley Sitko report on this Form 4?

Bradley Sitko reported grants of 44,849 Performance Stock Units and two awards of common-stock RSUs totaling 30,000 and 29,402 shares. These are compensation grants at no cash cost, not open-market stock purchases.

How do Bradley Sitko’s new XOMA RSU grants vest?

One RSU grant vests 100% on March 11, 2031, assuming continued service. A separate RSU grant vests 25% on each of the first four anniversaries of March 11, 2026, also subject to his continued service with XOMA.

How do the XOMA Performance Stock Units granted to Bradley Sitko work?

Each of the 44,849 Performance Stock Units represents a contingent right to receive one share of XOMA common stock. The PSUs vest only if the common stock reaches specified price levels and Sitko continues serving the company through each applicable vesting date.

Did Bradley Sitko buy or sell XOMA shares in the market in this Form 4?

No market buys or sells are reported. All transactions coded "A" reflect grant or award acquisitions of PSUs and RSUs at a price of $0.00 per share, indicating equity compensation rather than open-market trading activity.

What are Bradley Sitko’s direct XOMA common stock holdings after these awards?

After the reported grants, Sitko directly owns 79,224 shares of XOMA common stock. In addition, he holds 44,849 Performance Stock Units that may convert into common shares if vesting and stock-price conditions are satisfied.

What preferred and depositary shares linked to XOMA does Bradley Sitko report?

Sitko reports direct holdings of 313 shares of 8.625% Series A Cumulative Perpetual Preferred Stock and 7,045 depositary shares of 8.375% Series B Cumulative Stock. He also reports additional indirect preferred and depositary share holdings through his spouse.

What indirect XOMA holdings does Bradley Sitko disclose for himself and family?

Indirectly, Sitko reports 829 common shares through a 401(k) plan, 1,500 common shares held by his spouse, and 75 common shares held by each of two children, plus 82 Series A preferred and 2,000 Series B depositary shares held by his spouse.
XOMA Royalty Corporation

NASDAQ:XOMA

View XOMA Stock Overview

XOMA Rankings

XOMA Latest News

XOMA Latest SEC Filings

XOMA Stock Data

319.32M
12.16M
Biotechnology
Pharmaceutical Preparations
Link
United States
EMERYVILLE